San Diego, CA, United States of America

Andrew Xian Chen

USPTO Granted Patents = 36 

 

 

Average Co-Inventor Count = 1.9

ph-index = 6

Forward Citations = 208(Granted Patents)


Location History:

  • Cupertino, CA (US) (2011)
  • San Diego, CA (US) (2007 - 2024)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
36 patents (USPTO):Explore Patents

Hello! I'd be happy to help you with the article about inventor Andrew Xian Chen.

Title: A Glimpse into the Innovations of Andrew Xian Chen

Introduction: Andrew Xian Chen, a prolific inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals with a remarkable 33 patents to his name.

Latest Patents: Among his recent patents is the groundbreaking "Aqueous formulation for insoluble drugs," a clear one-phase liquid formulation that revolutionizes drug delivery. Additionally, his invention "Methods and compositions for treating edema refractory to oral diuretics" showcases his innovative approach to medical treatments.

Career Highlights: Andrew Xian Chen has garnered experience and expertise working with notable companies such as Latitude Pharmaceuticals, Inc. and Dr. Reddy's Laboratories, Incorporated. His diverse professional background has shaped his inventive mindset and propelled his success in the industry.

Collaborations: Throughout his career, Andrew Xian Chen has collaborated with talented individuals like Hailiang Chen and Franklin W Okumu, enriching his projects with unique perspectives and expertise.

Conclusion: In conclusion, Andrew Xian Chen stands as a trailblazing inventor whose relentless pursuit of innovation has led to groundbreaking advancements in pharmaceutical formulations and medical treatments. His impressive portfolio of patents underscores his commitment to pushing the boundaries of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…